---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-035978"
form_type: "8-K"
ticker: "SRTS"
cik: "0001494891"
company_name: "Sensus Healthcare, Inc."
filed_at: "2023-05-03T23:59:59+00:00"
generated_at: "2026-06-16T00:57:38.805664+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Sensus Healthcare Q1 2023 revenue $3.4M; net loss $1.9M; expects H2 profitability

## Summary
- Revenue $3.4M vs $10.3M YoY; shipped 10 SRT systems vs 33.
- Net loss $1.9M ($0.12 per share) vs net income $16.1M ($0.97 per share) in Q1 2022 (included $12.8M gain).
- Gross margin fell to 47.1% from 68.9% due to lower volume and vendor cost increases.
- Ended Q1 with $19.3M cash, no debt; expects >60 SRT shipments in 2023 and return to profitability in H2.
- Management cites inflation impacting dermatologists' cash flow; higher selling & marketing expense.

## SEC filing metadata
- accession: 0001213900-23-035978
- form_type: 8-K
- ticker: SRTS
- cik: 0001494891
- company_name: Sensus Healthcare, Inc.
- filed_at: 2023-05-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1494891/000121390023035978/0001213900-23-035978-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1494891/000121390023035978/ea177605-8k_sensus.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-035978
- JSON: https://secwatch.observer/filing/0001213900-23-035978.json
- Plain text: https://secwatch.observer/filing/0001213900-23-035978.txt

## Key facts
- Earnings Releases
  Sensus Healthcare, Inc. reported the three months ended March 31, 2023 results: revenue $3.4 million, net income Net loss was $1.9 million, or $0.12 per share.
  - Period: the three months ended March 31, 2023
  - Revenue: $3.4 million
  - Net income: Net loss was $1.9 million, or $0.12 per share
  - Result: reported results
  source text: from the first quarter of 2023 and recent weeks include the following (all comparisons are with the first quarter of 2022, unless otherwise indicated): ● Revenues were $3.4 million, compared with $10.3 million, reflecting lower SRT unit sales ● Shipped 10 systems including three SRT systems to Asia and six domestic SRT systems, compared with 33 ● Net loss
  evidence_url: https://www.sec.gov/Archives/edgar/data/1494891/000121390023035978/0001213900-23-035978-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.